Hepatocellular carcinoma screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
According to the American Association of Liver Diseases recommendations, screening for hepatocellular carcinoma by [[ultrasound]] (US) is recommended among patients with [[hepatitis B]], [[hepatitis C]], and [[cirrhosis]]. Screening is also recommended for Asian men over the age of 40, Asian women over the age of 50, and African American. | According to the American Association of Liver Diseases recommendations, screening for hepatocellular carcinoma by [[ultrasound]] (US) is recommended among patients with [[hepatitis B]], [[hepatitis C]], and [[cirrhosis]]. Screening is also recommended for Asian men over the age of 40, Asian women over the age of 50, and African American. | ||
==Screening== | ==Screening== | ||
Screening for hepatocellular carcinoma by [[ultrasound]] recommended for the following: | Screening for hepatocellular carcinoma by abdominal [[ultrasound]] and serum levels of [[alpha-fetoprotein]] is recommended for the following populations: | ||
*[[ | *Patients with [[hepatitis B]] | ||
*[[ | *Patients with [[hepatitis C]] | ||
*[[Cirrhosis]] | *Patietns with[[Cirrhosis]] | ||
*Asian men over the age of 40 | *Asian men over the age of 40 | ||
*Asian women over the age of 50 | *Asian women over the age of 50 | ||
Revision as of 16:00, 10 September 2015
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma screening On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma screening |
|
Risk calculators and risk factors for Hepatocellular carcinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
According to the American Association of Liver Diseases recommendations, screening for hepatocellular carcinoma by ultrasound (US) is recommended among patients with hepatitis B, hepatitis C, and cirrhosis. Screening is also recommended for Asian men over the age of 40, Asian women over the age of 50, and African American.
Screening
Screening for hepatocellular carcinoma by abdominal ultrasound and serum levels of alpha-fetoprotein is recommended for the following populations:
- Patients with hepatitis B
- Patients with hepatitis C
- Patietns withCirrhosis
- Asian men over the age of 40
- Asian women over the age of 50
- African American